---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-032093"
form_type: "8-K"
ticker: "DNA"
cik: "0001830214"
company_name: "Ginkgo Bioworks Holdings, Inc."
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T22:00:13.919898+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Ginkgo Bioworks Q1 revenue $19M (-49% YoY); narrows net loss; cash burn guidance reaffirmed

## Summary
- Revenue $19M, down 49% YoY; prior year included $7M non-cash deferred revenue release; adjusted EBITDA -$42M.
- GAAP net loss from continuing ops -$76M (vs -$83M prior year); operating cash burn trajectory reaffirmed.
- Completed Biosecurity divestiture on April 3, 2026; results presented as discontinued ops.
- Cash, cash equivalents and marketable securities $373M as of March 31, 2026.
- Reaffirms FY 2026 total cash burn guidance of $(150)-$(125) million.

## SEC filing metadata
- accession: 0001628280-26-032093
- form_type: 8-K
- ticker: DNA
- cik: 0001830214
- company_name: Ginkgo Bioworks Holdings, Inc.
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1830214/000162828026032093/0001628280-26-032093-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1830214/000162828026032093/dna-20260507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-032093
- JSON: https://secwatch.observer/filing/0001628280-26-032093.json
- Plain text: https://secwatch.observer/filing/0001628280-26-032093.txt

## Key facts
- Earnings Releases
  Ginkgo Bioworks Holdings, Inc. reported the first quarter ended March 31, 2026 results: revenue $19 million, net income $(76) million. Guidance reaffirmed.
  - Period: the first quarter ended March 31, 2026
  - Revenue: $19 million
  - Net income: $(76) million
  - Guidance: reaffirmed
  - Result: reported results
  source text: • First quarter 2026 Revenue of $19 million compared to $38 million in the comparable prior year period, a decrease of 49%. As previously reported, the first quarter of 2025 benefited from $7 million of non-cash revenue from previously announced release of deferred revenue relating to the mutual termination of a customer agreement. Excluding this non-cash deferred revenue release, first quarter 2026 Revenue of $19 million, down from $31 million in the comparable prior year period, a decrease of 37%. The decrease in revenue is primarily attributed to ongoing program rationalization as part of our restructuring activities. • First quarter 2026 GAAP net loss from continuing operations of $(76) million, compared to $(83) million in the comparable prior year period.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000162828026032093/0001628280-26-032093-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.